UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 24, 2020 4:00 P.M.
Form: S-4
CIK: 0001479290
Company Name: Revance Therapeutics, Inc.
File Number: 333-239059